The Scientist

» planar-cell polarity and disease/medicine

Most Recent

image: Environmental Impact

Environmental Impact

By David Berreby | March 1, 2011

Research in behavioral epigenetics is seeking evidence that links experience to biochemistry to gene expression and back out again.


image: Resistant to Failure

Resistant to Failure

By Cristina Luiggi | March 1, 2011

A Duke University researcher survives a sticky situation at a federal research institution to make major strides in determining the genetic roots of Staphylococcus aureus antibiotic resistance.


image: Mitotic Hijacker

Mitotic Hijacker

By Richard P. Grant | March 1, 2011

How a parasite sneakily ensures its own replication


image: Top 7 From F1000

Top 7 From F1000

By N/A | March 1, 2011

A snapshot of the highest-ranked articles from a 30-day period on Faculty of 1000


image: Face to Face with the Emotional Brain

Face to Face with the Emotional Brain

By Ahmad R. Hariri & Paul J. Whalen | February 1, 2011

Amygdala responses to the facial signals of others predict both normal and abnormal emotional states. An understanding of the brain chemistry underlying these responses will lead to new strategies for treating and predicting psychopathology.


image: Death or Damage of Dopamine Neurons

Death or Damage of Dopamine Neurons

By Bobby Thomas and M. Flint Beal | February 1, 2011

The hallmark pathology of Parkinson’s disease is the damage and death of dopamine producing neurons in the brain. 


image: The Genes of Parkinson’s Disease

The Genes of Parkinson’s Disease

By Bobby Thomas and M. Flint Beal | February 1, 2011

The minority of Parkinson’s cases now known to have genetic origins are shedding light on the cellular mechanisms of all the rest, bringing researchers closer to a cause—and perhaps a cure.


image: Down but Not Out

Down but Not Out

By Richard P. Grant | February 1, 2011

Cells on standby are surprisingly busy.


image: Puzzle Me This

Puzzle Me This

By Graeme Stemp-Morlock | February 1, 2011

What substance is supposed to have no effect but can make people feel better, has no chance for a big monetary payoff but is worth billions, and is used in virtually every rigorous clinical trial but has no single, universal formulation? 


image: Synthetic Spirits

Synthetic Spirits

By David Nutt | January 1, 2011

Can we use science to reduce the harms of alcohol?


Popular Now

  1. Could Rapamycin Help Humans Live Longer?
  2. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  3. University of Oregon Erecting a $1-Billion Science Center
  4. <em>Homo Sapiens</em> Interbred With Denisovans From Two Different Populations